Penserra Capital Management LLC Amicus Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$9.82 - $12.44 $59,902 - $75,884	-6,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $393 - $532	45 Added 0.74%	6,100 $58,000
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $1,306 - $1,608	150 Added 2.54%	6,055 $58,000
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $1,104 - $2,863	-120 Reduced 1.99%	5,905 $58,000
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $27,195 - $50,252	-2,019 Reduced 25.1%	6,025 $139,000
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $28,229 - $34,799	-2,190 Reduced 21.4%	8,044 $113,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $90,673 - $160,571	10,234 New	10,234 $154,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.